MRP ₹1440
(Inclusive of all Taxes)
₹216.0 Cashback (15%)
Provide Delivery Location
About Tresiba 100U/ml Penfil Injection 3 ml
Tresiba 100U/ml Penfil Injection 3 ml used for the treatment of both type 1 and type 2 diabetes mellitus. In Type 1 Diabetes Mellitus, the body does not produce enough insulin to regulate blood sugar levels. In type 2 diabetes mellitus, either the body stops producing enough insulin (a hormone that helps lower blood sugar levels) or there is resistance to the action of insulin. As a result, insulin is produced in large quantities, but it is unable to function correctly in the body's organs.
Tresiba 100U/ml Penfil Injection 3 ml contains insulin degludec, which helps normalise blood sugar levels by facilitating the movement of sugar from the blood into other tissues of the body. It reduces the risk of severe diabetes complications. It stimulates the recovery of sugar in muscle and fat cells, thereby suppressing the production of sugar in the liver.
Not everyone who is taking Tresiba 100U/ml Penfil Injection 3 ml will get these side effects. You may experience rash, injection site allergic reaction, weight gain, edema (tissue swelling or fluid overload), skin thickening at the injection site, low blood glucose levels, and itching. Most of these side effects of Tresiba 100U/ml Penfil Injection 3 ml do not require medical attention and typically resolve on their own over time. However, if the side effects are persistent, reach out to your doctor.
Tresiba 100U/ml Penfil Injection 3 ml should be taken before food or advised by your doctor. It should be administered subcutaneously (in the upper thigh, abdomen, upper arm, or buttocks) only. Your doctor will explain how to administer the medicine yourself. However, if it is difficult to inject the medicine, ask a healthcare professional to take it. Along with Tresiba 100U/ml Penfil Injection 3 ml , you should maintain a healthy diet, engage in regular exercise, and adhere to your doctor's weight management advice.
Inform your doctor if you are allergic to Tresiba 100U/ml Penfil Injection 3 ml . Do not take Tresiba 100U/ml Penfil Injection 3 ml if you have any low blood glucose levels, kidney, liver, or heart problems, or problems with alcohol or other prescription or recreational drugs. Try not to stop receiving Tresiba 100U/ml Penfil Injection 3 ml of your own. Let your doctor know about this, as it may cause withdrawal symptoms. Tresiba 100U/ml Penfil Injection 3 ml is a cold chain medicine, and so it must be stored in the refrigerator between 2-8 degrees Celsius, or else its efficiency might get lost. Do not store in the freezer or the fridge.
Uses of Tresiba 100U/ml Penfil Injection 3 ml
Tresiba 100U/ml Penfil Injection 3 ml is used in the treatment of Diabetes (type 1 diabetes mellitus and type 2 diabetes mellitus). The detailed uses of Tresiba 100U/ml Penfil Injection 3 ml are as follows:

Have a query?
Directions for Use
Key Benefits
How Tresiba 100U/ml Penfil Injection 3 ml Works
Storage
What if I have taken an overdose of Tresiba 100U/ml Penfil Injection 3 ml
Drug Warnings
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Safe if prescribed
You are recommended not to consume alcohol along with Tresiba 100U/ml Penfil Injection 3 ml to avoid unpleasant side-effects. Alcohol may either decrease or increase the blood sugar level which can be fatal.
Pregnancy
Consult your doctor
Tresiba 100U/ml Penfil Injection 3 ml can be used during pregnancy. Your insulin dose may need to be changed during pregnancy and after delivery.
Breast Feeding
Consult your doctor
Tresiba 100U/ml Penfil Injection 3 ml can be given safely to nursing mothers but only under the supervision of a physician.
Driving
Safe if prescribed
Drive with caution, Tresiba 100U/ml Penfil Injection 3 ml usually causes drowsiness and affects driving ability. Your ability to concentrate and react may be reduced if you have hypoglycaemia (low blood sugar).
Liver
Consult your doctor
Tresiba 100U/ml Penfil Injection 3 ml to be taken with caution, especially if you have a history of liver diseases/conditions. The dose may have to be adjusted by your doctor.
Kidney
Consult your doctor
Tresiba 100U/ml Penfil Injection 3 ml to be taken with caution, especially if you have a history of kidney diseases/conditions. The dose may have to be adjusted by your doctor.
Children
Safe if prescribed
Tresiba 100U/ml Penfil Injection 3 ml can be given safely to children more than 1-year-old; dose has to be prescribed by a child specialist.
Heart
Tresiba 100U/ml Penfil Injection 3 ml should be administered with caution in patients with heart problems. Please inform your doctor about any existing heart problems before using Tresiba 100U/ml Penfil Injection 3 ml .
Geriatrics
Consult your doctor
Tresiba 100U/ml Penfil Injection 3 ml should be administered with caution in elderly patients. If you have any concerns, please consult your doctor.
Tresiba 100U/ml Penfil Injection 3 ml is used for the treatment of type 1 and type 2 diabetes mellitus in both children (above 1 year of age) and adults.
Tresiba 100U/ml Penfil Injection 3 ml is only a part of a complete diabetes control program that includes regular blood sugar testing, diet, exercise, weight control, and special medical care. So follow all the instructions given by the doctor.
It is advised to tell all the medicines that you are using like pioglitazone or rosiglitazone as taking other diabetes medicines may increase the risk of serious heart problems.
Tresiba 100U/ml Penfil Injection 3 ml typically begins working after 60 minutes and will last for more than 24 hours.
Tresiba 100U/ml Penfil Injection 3 ml can be given to treat both the condition of type 1 and type 2 diabetes mellitus. However, your doctor will decide whether Tresiba 100U/ml Penfil Injection 3 ml can be given to you or not depending on your present condition. Tresiba 100U/ml Penfil Injection 3 ml should be avoided in patients who are allergic to Tresiba 100U/ml Penfil Injection 3 ml or other forms of insulin, patients with kidney disease, liver disease, low blood sugar/glucose level (hypoglycemia), and low potassium level (hypokalaemia).
Try to avoid intake of alcoholic beverages with Tresiba 100U/ml Penfil Injection 3 ml as it may increase or decrease your blood sugar level.
Cold sweat; cool pale skin; headache; rapid heartbeat; feeling sick; feeling very hungry; temporary vision changes; drowsiness; unusual tiredness and weakness; nervousness or tremor; feeling anxious; feeling confused; difficulty in concentrating are some of the common signs of the low blood sugar level in an individual.
If you experience low blood sugar, eat glucose tablets, or another high sugar snack (e.g. sweets, biscuits, fruit juice). Measure your blood sugar if possible and rest. Always carry glucose tablets or high sugar snacks with you. You should give a call to any of your family members if you are feeling dizziness or drowsiness.
Local allergic reactions (pain, redness, hives, inflammation, bruising, swelling, and itching) at the injection site may occur. These usually disappear after a few weeks of taking your insulin. If they do not disappear, or if they spread throughout your body, talk to your doctor immediately.
You can inject Tresiba 100U/ml Penfil Injection 3 ml in your upper arm, thigh, or stomach area. Do not inject Tresiba 100U/ml Penfil Injection 3 ml into your vein or muscle. Try to change (rotate) the injection site with each dose to avoid skin irritation in the same injection site.
If you have opened the insulin pen once, it must be stored at room temperature (25-degree Celsius) and may be used for up to 56 days after its first use.
Cut back on foods high in sodium, alcohol, fried foods, and high-carb food and drinks like sugary drinks, drinks with added sugar, white rice and starchy vegetables.
Tresiba 100U/ml Penfil Injection 3 ml should not be discontinued without a doctor's consultation as stopping Tresiba 100U/ml Penfil Injection 3 ml may cause severe hypoglycaemia (low blood sugar) and ketoacidosis (buildup of acid in the blood). Consult the doctor if you feel uncomfortable after taking Tresiba 100U/ml Penfil Injection 3 ml .
The injection site should be changed to prevent skin changes like lumps under the skin. Tresiba 100U/ml Penfil Injection 3 ml may not work well if injected into the lumpy area.
Maintain a healthy diet and exercise regularly. Limit sugar intake and avoid smoking & alcohol consumption. Manage stress by doing meditation or yoga.
Hypoglycaemia (low blood sugar) may occur because you inject too much insulin, miss or delay meals, do not eat enough, eat food containing less carbohydrate than normal, drink alcohol, lose carbohydrates due to vomiting or diarrhoea, do more exercise than usual or a different type of physical activity, are recovering from an injury, illness, operation or stress, or are taking/have stopped taking other medicines.
Tresiba 100U/ml Penfil Injection 3 ml is a long-acting human insulin analogue produced by rDNA process in Saccharomyces cerevisiae followed by chemical modification.
No, insulin glargine and Tresiba 100U/ml Penfil Injection 3 ml are not the same. Tresiba 100U/ml Penfil Injection 3 ml contains insulin degludec which has a longer half-life compared to insulin glargine. Insulin degludec and insulin glargine provide similar glycemic control, but insulin degludec also lowers the risk of low blood sugar.
Tresiba 100U/ml Penfil Injection 3 ml contains insulin degludec. Insulin degludec and insulin detemir were found to be equally effective in managing blood sugar levels.
Avoid sharing Tresiba 100U/ml Penfil Injection 3 ml , insulin syringe or needle with other patients. Do not miss meals and regularly monitor blood sugar levels. Avoid driving or operating machinery until you know how this medicine affects you. Do not consume alcohol or use prescription or over-the-counter medicines that contain alcohol.
Yes, Tresiba 100U/ml Penfil Injection 3 ml can be used alone to treat diabetes. However, Tresiba 100U/ml Penfil Injection 3 ml can be used with other diabetic medicines if prescribed by the doctor.
Yes, Tresiba 100U/ml Penfil Injection 3 ml is a long-acting basal human insulin analogue that is used to improve glycaemic control in patients with diabetes mellitus.
Yes, Tresiba 100U/ml Penfil Injection 3 ml can cause weight gain due to the anabolic effects of insulin. Eating healthy food and exercising regularly may help manage weight gain.
Tresiba 100U/ml Penfil Injection 3 ml does not raise blood sugar. However, hyperglycaemia has been reported with repeated insulin injections into areas of localised cutaneous amyloidosis (clumps of abnormal proteins called amyloids build up in the skin). Also, changes in insulin regimen may cause high/low blood sugar levels.
Side effects of Tresiba 100U/ml Penfil Injection 3 ml include hypoglycaemia (low blood sugar level), local injection site reactions, lipodystrophy (fat deposition under the skin), rash, and pruritus (itching skin) which may occur at the injection site. Most of these side effects may not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
Country of origin
Manufacturer/Marketer address
Keep Refrigerated. Do not freeze.Prepaid payment required.
We provide you with authentic, trustworthy and relevant information
Recommended for a 30-day course: 2 Packets